These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Characterization of amyloidosis]. Yazaki M; Ikeda S Brain Nerve; 2014 Jul; 66(7):723-30. PubMed ID: 24998817 [TBL] [Abstract][Full Text] [Related]
4. [Systemic AA amyloidosis induced by benign neoplasms]. Bestard Matamoros O; Poveda Monje R; Ibernon Vilaró M; Carrera Plans M; Grinyó Boira JM Nefrologia; 2008; 28(1):93-8. PubMed ID: 18336138 [TBL] [Abstract][Full Text] [Related]
5. [New trends in the treatment of amyloidosis]. Martínez-Valle F; Gironella-Mesa M; Solans-Laqué R Med Clin (Barc); 2012 May; 138(15):667-72. PubMed ID: 22197598 [TBL] [Abstract][Full Text] [Related]
6. Primary cutaneous amyloidosis: a clinico-pathological study with emphasis on polarized microscopy. Vijaya B; Dalal BS; ; Manjunath GV Indian J Pathol Microbiol; 2012; 55(2):170-4. PubMed ID: 22771637 [TBL] [Abstract][Full Text] [Related]
7. The Pathology of Amyloidosis in Classification: A Review. Picken MM Acta Haematol; 2020; 143(4):322-334. PubMed ID: 32392555 [TBL] [Abstract][Full Text] [Related]
8. Current concepts on the pathogenesis of systemic amyloidosis. Bellotti V; Merlini G Nephrol Dial Transplant; 1996; 11 Suppl 9():53-62. PubMed ID: 9050036 [TBL] [Abstract][Full Text] [Related]
9. Renal Amyloidosis: A Clinicopathological Study From a Tertiary Care Hospital in Pakistan. Ahmed S; Nasir H; Moatasim A; Khalil F Cureus; 2022 Jan; 14(1):e21122. PubMed ID: 35165578 [TBL] [Abstract][Full Text] [Related]
10. Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature. Siragusa S; Morice W; Gertz MA; Kyle RA; Greipp PR; Lust JA; Witzig TE; Lacy MQ; Zeldenrust SR; Rajkumar SV; Russell SJ; Hayman SR; Buadi F; Kumar SK; Dingli D; Dispenzieri A Ann Hematol; 2011 Jan; 90(1):101-6. PubMed ID: 20645101 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and origin of amyloid in kidney biopsies. von Hutten H; Mihatsch M; Lobeck H; Rudolph B; Eriksson M; Röcken C Am J Surg Pathol; 2009 Aug; 33(8):1198-205. PubMed ID: 19561448 [TBL] [Abstract][Full Text] [Related]
17. Digitally reinforced polarization of hematoxylin-eosin in the diagnosis of renal amyloidosis. Sen S; Sarsik Kumbaraci B Turk Patoloji Derg; 2012; 28(3):204-12. PubMed ID: 23011822 [TBL] [Abstract][Full Text] [Related]
18. An evaluation of Congo red fluorescence for the diagnosis of amyloidosis. Clement CG; Truong LD Hum Pathol; 2014 Aug; 45(8):1766-72. PubMed ID: 24935061 [TBL] [Abstract][Full Text] [Related]
19. [Head and neck amyloidosis]. Leszczyńska M; Borucki L; Popko M Otolaryngol Pol; 2008; 62(5):643-8. PubMed ID: 19004276 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical identification of amyloid, using an anti-human serum amyloid P component (SAP) antibody, is possible in ruminants but not in dogs and cats. Hartig W; Leifsson PS; Nielsen OL J Vet Med A Physiol Pathol Clin Med; 2005 Nov; 52(9):447-53. PubMed ID: 16268955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]